{"paper_id":"c474f535-f959-4420-90a2-d35c77be7e96","body_text":"Abstract\nEndometriosis-associated infertility is a consequence of complex pathogenetic interactions occurring in the development and course of disease, owing to genetic and epigenetic mechanisms. Predominant causative factors for impaired fecundity due to endometriosis pertain to decreased oocyte count and aberrant morphology that emerge due to inflammatory events, oxidative stress, meiotic spindle and cytoskeleton abnormalities and epigenetic alterations, along with hormonal imbalances and dysregulated gene expression. Oocyte and embryo competence are affected by these alterations, hindering assisted reproduction outcomes by lowering fertilization, hatching and pregnancy rates, and increasing incidence of aneuploidy. The effects on oocyte and embryo quality in IVF success are not presented in a distinctive manner, due to the multifactorial nature of disease. Therefore, the identification and development of prognostic biomarkers would enable the implementation of personalized medicine, for the optimal management of endometriosis-associated infertility.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nVassilopoulou L, Matalliotakis M, Zervou M, Matalliotaki C, Krithinakis K, Matalliotakis I, et al. Defining the genetic profile of endometriosis (review). Exp Ther Med. 2019;17:3267–81.\nBulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–79.\nKasapoglu I, Kuspinar G, Saribal S, Turk P, Avcı B, Uncu G. Detrimental effects of endometriosis on oocyte morphology in intracytoplasmic sperm injection cycles: a retrospective cohort study. Gynecol Endocrinol. 2018;34(3):206–11. https://doi.org/10.1080/09513590.2017.1391203.\nShebl O, Sifferlinger I, Habelsberger A, Oppelt P, Mayer RB, Petek E, et al. Oocyte competence in in vitro fertilization and intracytoplasmic sperm injection patients suffering from endometriosis and its possible association with subsequent treatment outcome: a matched case–control study. Acta Obstet Gynecol Scand. 2017;96(6):736–44.\nStilley JAW, Birt JA, Sharpe-Timms KL. Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res. 2012;349(3):849–62.\nvan der Linden P. Theories on the pathogenesis of endometriosis. Hum Reprod. 1996;11(3):42–53.\nBrosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: are the changes of clinical significance? Reprod Biomed. 2012;24(5):496–502. https://doi.org/10.1016/j.rbmo.2012.01.022.\nVassilopoulou L, Matalliotakis M, Zervou MI, Matalliotaki C, Spandidos DA, Matalliotakis I, et al. Endometriosis and in vitro fertilisation (review). Exp Ther Med. 2018;16:1043–51.\nDe Wilde RL, Alvarez J, Brölmann H, Campo R, Cheong Y, Lundorff P, et al. Adhesions and endometriosis: challenges in subfertility management: (an expert opinion of the ANGEL-the ANti-adhesions in Gynaecology expert PaneL-group). Arch Gynecol Obstet. 2016;294(2):299–301.\nSimopoulou M, Rapani A, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, et al. Getting to know endometriosis-related infertility better: a review on how endometriosis affects oocyte quality and embryo development. Biomedicine. 2021;9(273):1–22.\nDing Y, Zhu Q, He Y, Lu Y, Wang Y, Qi J, et al. Induction of autophagy by Beclin-1 in granulosa cells contributes to follicular progesterone elevation in ovarian endometriosis. Transl Res. 2021;227:15–29. https://doi.org/10.1016/j.trsl.2020.06.013.\nXu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, et al. Oocyte quality is decreased in women with minimal or mild endometriosis. Sci Rep. 2015;5:1–8.\nDonabela FC, Meola J, Padovan CC, De Paz CCP, Navarro PA. Higher SOD1 gene expression in cumulus cells from infertile women with moderate and severe endometriosis. Reprod Sci. 2015;22(11):1452–60.\nSeino T, Saito H, Kaneko T, Takahashi T, Kawachiya S, Kurachi H. Eight-hydroxy-2′-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril. 2002;77(6):1184–90.\nVárnagy Á, Kőszegi T, Györgyi E, Szegedi S, Sulyok E, Prémusz V, et al. Levels of total antioxidant capacity and 8-hydroxy-2′-deoxyguanosine of serum and follicular fluid in women undergoing in vitro fertilization: focusing on endometriosis. Hum Fertil. 2020;23(3):200–8. https://doi.org/10.1080/14647273.2018.1535719.\nDa Broi MG, de Albuquerque FO, de Andrade AZ, Cardoso RL, Jordão Junior AA, Navarro PA. Increased concentration of 8-hydroxy-2′-deoxyguanosine in follicular fluid of infertile women with endometriosis. Cell Tissue Res. 2016;366(1):231–42. https://doi.org/10.1007/s00441-016-2428-4.\nSong Y, Liu J, Qiu Z, Chen D, Luo C, Liu X, et al. Advanced oxidation protein products from the follicular microenvironment and their role in infertile women with endometriosis. Exp Ther Med. 2018;15(1):479–86.\nSantanam N, Zoneraich N, Parthasarathy S. Myeloperoxidase as a potential target in women with endometriosis undergoing IVF. Reprod Sci. 2017;24(4):619–26.\nChoi WJ, Banerjee J, Falcone T, Bena J, Agarwal A, Sharma RK. Oxidative stress and tumor necrosis factor-α-induced alterations in metaphase II mouse oocyte spindle structure. Fertil Steril. 2007;88(2):1220–31.\nChoi YS, Cho SH, Seo SK, Park JH, Kim SH, Lee BS. Alteration in the intrafollicular thiol-redox system in infertile women with endometriosis. Reproduction. 2015;149(2):155–62.\nDa Broi MG, Navarro PA. Oxidative stress and oocyte quality: ethiopathogenic mechanisms of minimal/mild endometriosis-related infertility. Cell Tissue Res. 2016;364(1):1.\nGupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. 2008;90(2):247–57.\nMansour G, Abdelrazik H, Sharma RK, Radwan E, Falcone T, Agarwal A. L-carnitine supplementation reduces oocyte cytoskeleton damage and embryo apoptosis induced by incubation in peritoneal fluid from patients with endometriosis. Fertil Steril. 2009;91(5):2079–86. https://doi.org/10.1016/j.fertnstert.2008.02.097.\nBarcelos ID, Vieira RC, Ferreira EM, Martins WP, Ferriani RA, Navarro PA. Comparative analysis of the spindle and chromosome configurations of in vitro-matured oocytes from patients with endometriosis and from control subjects: a pilot study. Fertil Steril. 2009;92(5):1749–52. https://doi.org/10.1016/j.fertnstert.2009.05.006.\nRajani S, Chattopadhyay R, Goswami S, Ghosh S, Sharma S, Chakravarty B. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. 2012;5(2):187–93.\nBalkowiec M, Maksym RB, Wlodarski PK. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (review). Mol Med Rep. 2018;18(3):3123–36.\nStilley JAW, Woods-Marshall R, Sutovsky M, Sutovsky P, Sharpe-Timms KL. Reduced fecundity in female rats with surgically induced endometriosis and in their daughters: a potential role for tissue inhibitors of metalloproteinase. Biol Reprod. 2009;80(4):649–56.\nZhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, et al. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci. 1998;111(9):1147–53.\nGiorgi VSI, Ferriani RA, Navarro PA. Follicular fluid from infertile women with mild endometriosis impairs in vitro bovine embryo development: potential role of oxidative stress. Rev Bras Ginecol Obstet. 2021;43(2):119–25.\nHorton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:593–633.\nGiorgi VSI, Da Broi MG, Paz CCP, Ferriani RA, Navarro PA. N-acetyl-cysteine and l-carnitine prevent meiotic oocyte damage induced by follicular fluid from infertile women with mild endometriosis. Reprod Sci. 2016;23(3):342–51.\nCohen J, Ziyyat A, Naoura I, Chabbert-Buffet N, Aractingi S, Darai E, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2015;32(2):263–70.\nDa Broi MG, Malvezzi H, Paz CCP, Ferriani RA, Navarro PAAS. Follicular fluid from infertile women with mild endometriosis may compromise the meiotic spindles of bovine metaphase II oocytes. Hum Reprod. 2013;29(2):315–23.\nJianini BTGM, Giorgi VSI, Da Broi MG, De Paz CCP, Rosa Silva JCE, Ferriani RA, et al. Peritoneal fluid from infertile women with minimal/mild endometriosis compromises the meiotic spindle of metaphase II bovine oocytes: a pilot study. Reprod Sci. 2017;24(9):1304–11.\nOrazov MR, Radzinsky VY, Ivanov II, Khamoshina MB, Shustova VB. Oocyte quality in women with infertility associated endometriosis. Gynecol Endocrinol. 2019;35(sup1):24–6. https://doi.org/10.1080/09513590.2019.1632088.\nRadzinsky VY, Orazov MR, Ivanov II, Khamoshina MB, Ivanov II, Kavteladze EV, et al. Implantation failures in women with infertility associated endometriosis. Gynecol Endocrinol. 2019;35(S1):27–30. https://doi.org/10.1080/09513590.2019.1632089.\nXing W, Lin H, Wu Z, Li Y, Zhang Q. Effect of pelvic endometriosis, endometriomas and recurrent Endometriomas on IVF-ET/ICSI outcomes. Mater Socio Medica. 2016;28(2):91.\nGuo H, Gao H, Li J, Cong Y, Chen Q, Wang Y, et al. Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III–IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization. Ann Transl Med. 2020;8(6):377.\nBoucret L, Bouet P-E, Riou J, Legendre G, Delbos L, El HH, et al. Endometriosis lowers the cumulative live birth rates in IVF by decreasing the number of embryos but not their quality. J Clin Med. 2020;9(8):2478.\nBishop LA, Gunn J, Jahandideh S, Devine K, Decherney AH, Hill MJ. Endometriosis does not impact live-birth rates in frozen embryo transfers of euploid blastocysts. Fertil Steril. 2021;115(2):416–22. https://doi.org/10.1016/j.fertnstert.2020.07.050.\nJuneau C, Kraus E, Werner M, Franasiak J, Morin S, Patounakis G, et al. Patients with endometriosis have aneuploidy rates equivalent to their age-matched peers in the in vitro fertilization population. Fertil Steril. 2017;108(2):284–8. https://doi.org/10.1016/j.fertnstert.2017.05.038.\nPapaleo E, Ottolina J, Vigana P, Brigante C, Marsiglio E, De Michele F, et al. Deep pelvic endometriosis negatively affects ovarian reserve and the number of oocytes retrieved for in vitro fertilization. Acta Obstet Gynecol Scand. 2011;90(8):878–84.\nDe Conto E, Matte U, Cunha-Filho JS. BMP-6 and SMAD4 gene expression is altered in cumulus cells from women with endometriosis-associated infertility. Acta Obstet Gynecol Scand. 2021;100(5):868–75.\nBarcelos IDES, Donabella FC, Ribas CP, Meola J, Ferriani RA, De Paz CCP, et al. Down-regulation of the CYP19A1 gene in cumulus cells of infertile women with endometriosis. Reprod Biomed Online. 2015;30(5):532–41. https://doi.org/10.1016/j.rbmo.2015.01.012.\nda Luz CM, da Broi MG, Donabela FC, Paro de Paz CC, Meola J, Navarro PA. PTGS2 down-regulation in cumulus cells of infertile women with endometriosis. Reprod Biomed Online. 2017;35(4):379–86. https://doi.org/10.1016/j.rbmo.2017.06.021.\nEkart J, McNatty K, Hutton J, Pitman J. Ranking and selection of MII oocytes in human ICSI cycles using gene expression levels from associated cumulus cells. Hum Reprod. 2013;28(11):2930–42.\nKawabe S, Yamashita Y, Saito N, Kokunai K, Hayashi A, Hayashi M, et al. The effect of moderate to severe endometriosis on expression of growth differentiation factor-9 mRNA in human granulosa cells under controlled ovarian hyperstimulation. Reprod Med Biol. 2015;14(4):179–84.\nLi X, Zhang W, Fu J, Xu Y, Gu R, Qu R, et al. MicroRNA-451 is downregulated in the follicular fluid of women with endometriosis and influences mouse and human embryonic potential. Reprod Biol Endocrinol. 2019;17(1):1–11.\nda Silva LFI, Da Broi MG, da Luz CM, da Silva LECM, Ferriani RA, Meola J, et al. miR-532-3p: a possible altered miRNA in cumulus cells of infertile women with advanced endometriosis. Reprod Biomed Online. 2021;42(3):579–88. https://doi.org/10.1016/j.rbmo.2020.10.010.\nBaumann C, Olson M, Wang K, Fazleabas A, De La Fuente R. Arginine methyltransferases mediate an epigenetic ovarian response to endometriosis. Reproduction. 2015;150(4):297–310.\nFerrero H, Corachan A, Aguilar A, Quiñonero A, Carbajo-Garcia MC, Alama P, et al. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality. Hum Reprod. 2019;34(7):1302–12.\nSantonastaso M, Pucciarelli A, Costantini S, Caprio F, Sorice A, Capone F, et al. Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients. Mol Biosyst. 2017;13(6):1213–22. https://doi.org/10.1039/c7MB00181a.\nSingh AK, Dutta M, Chattopadhyay R, Chakravarty B, Chaudhury K. Intrafollicular interleukin-8, interleukin-12, and adrenomedullin are the promising prognostic markers of oocyte and embryo quality in women with endometriosis. J Assist Reprod Genet. 2016;33(10):1363–72. https://doi.org/10.1007/s10815-016-0782-5.\nWiweko B, Afdi QF, Harzif AK, Pratama G, Sumapradja K, Muharam R, et al. Analysis of factors associated with ovarian reserve in a group of poor responders to in vitro fertilization: a cross-sectional study. Int J Reprod Biomed. 2020;18(12):1065–72.\nPacchiarotti A, Iaconianni P, Caporali S, Vitillo M, Meledandri M, Monaco G, et al. Severe endometriosis: low value of AMH did not affect oocyte quality and pregnancy outcome in IVF patients. Eur Rev Med Pharmacol Sci. 2020;24(22):11488–95.\nBorges E, Braga DPAF, Setti AS, Vingris LS, Figueira RCS, Iaconelli A. Endometriosis affects oocyte morphology in intracytoplasmic sperm injection cycles. J Bras Reprod Assist. 2015;19(4):235–40.\nDe Carvalho BR, Rosa-E-Silva ACJDS, Rosa-E-Silva JC, Dos RRM, Ferriani RA, Silva-De-Sá MF. Increased basal FSH levels as predictors of low-quality follicles in infertile women with endometriosis. Int J Gynecol Obstet. 2010;110(3):208–12. https://doi.org/10.1016/j.ijgo.2010.03.033.\nGoud PT, Goud AP, Joshi N, Puscheck E, Diamond MP, Abu-Soud HM. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. 2014;102(1):151. https://doi.org/10.1016/j.fertnstert.2014.03.053.\nPauli SA, Session DR, Shang W, Easley K, Wieser F, Taylor RN, et al. Analysis of follicular fluid retinoids in women undergoing in vitro fertilization: retinoic acid influences embryo quality and is reduced in women with endometriosis. Reprod Sci. 2013;20(9):1116–24.\nDong F, Zhang Q, Kong W, Chen J, Ma J, Wang L, et al. Regulation of endometrial cell proliferation by estrogen-induced BDNF signaling pathway. Gynecol Endocrinol. 2017;33(6):485–9. https://doi.org/10.1080/09513590.2017.1295439.\nWu J, Yang X, Huang J, Kuang Y, Wang Y. Fertility and neonatal outcomes of freeze-all vs. Fresh embryo transfer in women with advanced endometriosis. Front Endocrinol (Lausanne). 2019;10:1–8.\nFreis A, Dietrich JE, Binder M, Holschbach V, Strowitzki T, Germeyer A. Relative morphokinetics assessed by time-lapse imaging are altered in embryos from patients with endometriosis. Reprod Sci. 2018;25(8):1279–85.\nGuo Y, Hong LN, Zhang Y, Chun SY, Wang Y, Le ZY, et al. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone ag. Contemp Clin Trials. 2012;33(6):1206–10.\nDecleer W, Osmanagaoglu K, Verschueren K, Comhaire F, Devroey P. RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Hum Reprod. 2016;31(9):2017–23.\nQiu Q, Huang J, Li Y, Chen X, Lin H, Li L, et al. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study. Hum Reprod. 2020;35(6):1411–20.\nSanchez AM, Pagliardini L, Cermisoni GC, Privitera L, Makieva S, Alteri A, et al. Does endometriosis influence the embryo quality and/or development? Insights from a large retrospective matched cohort study. Diagnostics. 2020;10(2):83.\nLin XN, Wei ML, Tong XM, Xu WH, Zhou F, Huang QX, et al. Outcome of in vitro fertilization in endometriosis-associated infertility: a 5-year database cohort study. Chin Med J. 2012;125(15):2688–93.\nBarbosa MAP, Teixeira DM, Navarro PAAS, Ferriani RA, Nastri CO, Martins WP. The impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44(3):261–78.\nScarafia C, Masciovecchio M, Canosa S, Carosso AR, Gennarelli G, Revelli A, et al. Does ovarian endometriosis increase oocyte sensitivity to ICSI-induced mechanical damage? J Clin Med. 2021;10(8):1757.\nAuthor information\nAuthors and Affiliations\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG\nAbout this chapter\nCite this chapter\nVassilopoulou, L., Matalliotakis, M., Matalliotaki, C., Krithinakis, K., Matalliotakis, I. (2024). The Effect of Endometriosis on the Quality of Oocytes and Embryos Obtained by IVF. In: Ferrero, S. (eds) Endometriosis-related Infertility. Springer, Cham. https://doi.org/10.1007/978-3-031-50662-8_16\nDownload citation\nDOI: https://doi.org/10.1007/978-3-031-50662-8_16\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-031-50661-1\nOnline ISBN: 978-3-031-50662-8\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}